Anthropic, led by Dario Amodei, and OpenAI, led by Sam Altman, engaged in talks earlier this year to create a legally binding agreement to stress-test each other's AI models for safety flaws. The deal aimed to have each company rigorously evaluate the other's new AI models to identify potential risks or hidden dangers. Although lawyers were drafting terms, it remains unclear if the agreement was finalized. This move reflects growing calls for peer review and stricter safety standards in AI development, amid concerns about rapid AI advancements and their potential risks. Industry leaders and critics continue debating the best approach to ensure AI safety, with some advocating for independent oversight and others skeptical of current proposals.
OpenAI and Anthropic's talks on AI model safety come as 129 of 150 priced Technology-sector US stocks tradable on Pluang rose today. For readers following technology stocks, here is Pluang's market snapshot as of Sep 21, 2026 23:33 WIB: AXTI gained 12.94% to USD 79.09 with a typical hold time of 16 days, AKAM rose 10.82% to USD 115.83 with a 48-day hold, and VNET increased 10.28% to USD 7.19 with a 15-day hold.
The global clinical trial supplies market is projected to grow from $5.7 billion in 2025 to $10.7 billion by 2033, at an 8.4% CAGR. This growth is driven by increased R&D investments, rising chronic diseases, and the expansion of biologics, personali...
Starlink Mobile, launched by VEON Ltd. across Ukraine, Kazakhstan, and Bangladesh, has connected over 11 million users in less than a year. The service enables existing 4G phones to access satellite connectivity where terrestrial signals are unavaila...
Medallion Financial Corp. announced it will repurchase $15 million in trust preferred securities from BIMIZCI Fund LLC at 73.66% of face value, costing about $11.05 million plus accrued distributions. This deal includes a five-year standstill agreeme...
Belite Bio, a clinical-stage drug developer focused on retinal diseases, has been approved to move its stock listing from the Nasdaq Capital Market to the Nasdaq Global Select Market, the highest tier on Nasdaq. This uplisting reflects the company's ...
Heineken N.V. has repurchased a total of 8,865,521 shares under the second tranche of its €1.5 billion share buyback program, spending €629.4 million as of October 16, 2026. This includes shares bought on the exchange and from Heineken Holding N.V. T...
